Search research articles
Contact Us
Filters
Showing results (291-300 of 327) with videos related to
Page
of 33
Sort By:
The Lancet. Oncology
|
March 1, 2008
Screening for gastric cancer in Asia: current evidence and practice
Wai K Leung, Ming-shiang Wu, Yasuo Kakugawa, et al.
Clinical and Molecular Hepatology
|
October 17, 2024
Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial
Yao-Chun Hsu, Chi-Yi Chen, Cheng-Hao Tseng, et al.
Journal of Hepatology
|
December 11, 2012
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
Chih-Wen Lin, Chih-Che Lin, Lein-Ray Mo, et al.
The Lancet. Gastroenterology & Hepatology
|
November 16, 2023
Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis
Tzu-Chan Hong, Emad M El-Omar, Yu-Ting Kuo, et al.
Journal of Gastroenterology and Hepatology
|
July 4, 2014
Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey
Khean Lee Goh, Myung Gyu Choi, William Ping I Hsu, et al.
Gut
|
March 16, 2011
The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects
Khay-Guan Yeoh, Khek-Yu Ho, Han-Mo Chiu, et al.
Journal of Clinical Gastroenterology
|
January 26, 2018
Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study
Tsung-Hsien Chiang, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, et al.
Gut
|
October 9, 2024
Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B
David Z Pan, Cameron M Soulette, Abhishek Aggarwal, et al.
The Lancet. Infectious Diseases
|
February 1, 2021
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
Yao-Chun Hsu, Chi-Yi Chen, I-Wei Chang, et al.
American Journal of Cancer Research
|
January 12, 2022
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies
Wei-Fan Hsu, Hung-Wei Wang, Cheng-Kuo Chen, et al.
Page
of 33
Search research articles
Search
Showing results (291-300 of 327) with videos related to
Sort By:
Page
of 33
The Lancet. Oncology
|
March 1, 2008
Screening for gastric cancer in Asia: current evidence and practice
Wai K Leung, Ming-shiang Wu, Yasuo Kakugawa, et al.
Clinical and Molecular Hepatology
|
October 17, 2024
Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial
Yao-Chun Hsu, Chi-Yi Chen, Cheng-Hao Tseng, et al.
Journal of Hepatology
|
December 11, 2012
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
Chih-Wen Lin, Chih-Che Lin, Lein-Ray Mo, et al.
The Lancet. Gastroenterology & Hepatology
|
November 16, 2023
Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis
Tzu-Chan Hong, Emad M El-Omar, Yu-Ting Kuo, et al.
Journal of Gastroenterology and Hepatology
|
July 4, 2014
Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey
Khean Lee Goh, Myung Gyu Choi, William Ping I Hsu, et al.
Gut
|
March 16, 2011
The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects
Khay-Guan Yeoh, Khek-Yu Ho, Han-Mo Chiu, et al.
Journal of Clinical Gastroenterology
|
January 26, 2018
Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study
Tsung-Hsien Chiang, Sherry Yueh-Hsia Chiu, Sam Li-Sheng Chen, et al.
Gut
|
October 9, 2024
Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B
David Z Pan, Cameron M Soulette, Abhishek Aggarwal, et al.
The Lancet. Infectious Diseases
|
February 1, 2021
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
Yao-Chun Hsu, Chi-Yi Chen, I-Wei Chang, et al.
American Journal of Cancer Research
|
January 12, 2022
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies
Wei-Fan Hsu, Hung-Wei Wang, Cheng-Kuo Chen, et al.
Page
of 33